Collaborative [ENAV] vs Exelixis [EXEL] Detailed Stock Comparison
Collaborative
NYSE
Loading...
Exelixis
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Collaborative wins in 5 metrics, Exelixis wins in 9 metrics, with 0 ties. Exelixis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Collaborative | Exelixis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 14.87 | 18.13 | Collaborative |
| Price-to-Book Ratio | 62.65 | 5.01 | Exelixis |
| Debt-to-Equity Ratio | -0.02 | 8.84 | Collaborative |
| PEG Ratio | 0.09 | 22.18 | Collaborative |
| EV/EBITDA | -121.16 | 12.21 | Collaborative |
| Profit Margin (TTM) | 99.92% | 27.01% | Collaborative |
| Operating Margin (TTM) | N/A | 37.58% | N/A |
| EBITDA Margin (TTM) | N/A | 37.58% | N/A |
| Return on Equity | 6.86% | 29.00% | Exelixis |
| Return on Assets (TTM) | -33.17% | 17.24% | Exelixis |
| Free Cash Flow (TTM) | N/A | $633.79M | N/A |
| 1-Year Return | 14.35% | 39.86% | Exelixis |
| Price-to-Sales Ratio (TTM) | 2,119.18 | 4.55 | Exelixis |
| Enterprise Value | $5.22B | $9.54B | Exelixis |
| EV/Revenue Ratio | 2,088.63 | 4.28 | Exelixis |
| Gross Profit Margin (TTM) | N/A | 96.57% | N/A |
| Revenue per Share (TTM) | $0 | $8 | Exelixis |
| Earnings per Share (Diluted) | $-0.27 | $2.08 | Exelixis |
| Beta (Stock Volatility) | N/A | 0.29 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Collaborative vs Exelixis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Collaborative | -0.20% | -0.12% | 1.70% | 11.48% | 6.06% | 8.97% |
| Exelixis | 0.88% | 1.23% | -13.31% | 3.34% | 12.60% | 11.14% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Collaborative | 14.35% | 517.45% | 2,597.54% | 1,062.90% | 2,511.90% | 2,511.90% |
| Exelixis | 39.86% | 93.63% | 71.61% | 548.11% | 1,209.72% | 368.57% |
Performance & Financial Health Analysis: Collaborative vs Exelixis
| Metric | ENAV | EXEL |
|---|---|---|
| Market Information | ||
| Market Cap | $5.30B | $10.15B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 1,176 | 5,486,740 |
| 90 Day Avg. Volume | 1,135 | 3,720,250 |
| Last Close | $32.91 | $37.72 |
| 52 Week Range | $26.31 - $33.31 | $25.12 - $49.62 |
| % from 52W High | -1.20% | -23.98% |
| All-Time High | $33.31 (Jul 31, 2025) | $50.50 (Jul 10, 2000) |
| % from All-Time High | -1.20% | -25.31% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -1.00% | -0.11% |
| Quarterly Earnings Growth | N/A | -0.18% |
| Financial Health | ||
| Profit Margin (TTM) | 1.00% | 0.27% |
| Operating Margin (TTM) | N/A | 0.38% |
| Return on Equity (TTM) | 0.07% | 0.29% |
| Debt to Equity (MRQ) | -0.02 | 8.84 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-4.04 | $7.53 |
| Cash per Share (MRQ) | N/A | $2.94 |
| Operating Cash Flow (TTM) | $-30,403,000 | $772.03M |
| Levered Free Cash Flow (TTM) | $-43,200,000 | $637.96M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Collaborative vs Exelixis
| Metric | ENAV | EXEL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 14.87 | 18.13 |
| Forward P/E | N/A | 22.18 |
| PEG Ratio | 0.09 | 22.18 |
| Price to Sales (TTM) | 2,119.18 | 4.55 |
| Price to Book (MRQ) | 62.65 | 5.01 |
| Market Capitalization | ||
| Market Capitalization | $5.30B | $10.15B |
| Enterprise Value | $5.22B | $9.54B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2,088.63 | 4.28 |
| Enterprise to EBITDA | -121.16 | 12.21 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.29 |
| Book Value per Share (MRQ) | $-4.04 | $7.53 |
Financial Statements Comparison: Collaborative vs Exelixis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ENAV | EXEL |
|---|---|---|
| Revenue/Sales | N/A | $555.45M |
| Cost of Goods Sold | N/A | $19.17M |
| Gross Profit | N/A | $536.28M |
| Research & Development | N/A | $212.23M |
| Operating Income (EBIT) | N/A | $186.86M |
| EBITDA | N/A | $194.20M |
| Pre-Tax Income | N/A | $205.69M |
| Income Tax | N/A | $46.07M |
| Net Income (Profit) | N/A | $159.62M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ENAV | EXEL |
|---|---|---|
| Cash & Equivalents | N/A | $183.75M |
| Total Current Assets | N/A | $1.40B |
| Total Current Liabilities | N/A | $399.10M |
| Long-Term Debt | N/A | $187.13M |
| Total Shareholders Equity | N/A | $2.13B |
| Retained Earnings | N/A | $-163.29M |
| Property, Plant & Equipment | N/A | $338.58M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ENAV | EXEL |
|---|---|---|
| Operating Cash Flow | N/A | $186.51M |
| Capital Expenditures | N/A | $-2.95M |
| Free Cash Flow | N/A | $188.99M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-283.93M |
Short Interest & Institutional Ownership Analysis
| Metric | ENAV | EXEL |
|---|---|---|
| Shares Short | N/A | 18.27M |
| Short Ratio | N/A | 4.91 |
| Short % of Float | N/A | 0.09% |
| Average Daily Volume (10 Day) | 1,176 | 5,486,740 |
| Average Daily Volume (90 Day) | 1,135 | 3,720,250 |
| Shares Outstanding | 160.66M | 281.73M |
| Float Shares | N/A | 228.77M |
| % Held by Insiders | N/A | 0.02% |
| % Held by Institutions | N/A | 0.95% |
Dividend Analysis & Yield Comparison: Collaborative vs Exelixis
| Metric | ENAV | EXEL |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.03 | N/A |
| 3-Year Avg Dividend Yield | 0.34% | N/A |
| 3-Year Total Dividends | $0.09 | N/A |
| Ex-Dividend Date | Dec 19, 2023 | N/A |